Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

American Journal of Gastroenterology

Volumn 111, Issue 4, 2016, Pages 523-528

  Nardelli, Silvia ^a   Gioia, Stefania ^a   Pasquale, Chiara ^a   Pentassuglio, Ilaria ^a   Farcomeni, Alessio ^a,b   Merli, Manuela ^a   Salvatori, Filippo Maria ^a   Nikolli, Leandra ^a   Torrisi, Sabrina ^a   Greco, Francesca ^a   Nicoletti, Valeria ^a   Riggio, Oliviero ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; BILIRUBIN; DISACCHARIDE; SODIUM;

ADULT; AGED; ARTICLE; ASCITES; CHILD PUGH SCORE; COGNITIVE DEFECT; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; INCIDENCE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; PSYCHOMETRY; RISK FACTOR; SODIUM BLOOD LEVEL; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; LIVER CIRRHOSIS; MIDDLE AGED;

ADULT; AGED; COGNITIVE DYSFUNCTION; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PSYCHOMETRICS; RISK FACTORS;

EID: 84959528111     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.29     Document Type: Article

References (35)

1. Cabrera J, Maynar M, Granados R, et al. Transjugular intrahepatic portosystemic shunt versus sclerotheraphy in the elective treatment of variceal hemorrage. Gastroenterology 1996; 110: 832-9
2. Sanjal AJ, Freedman AM, Luketic VA, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotheraphy. Gastroenterology 1996; 111: 138-46
3. Rossle M, Deibert P, Haag K, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propanolol for prevention of variceal rebleeding. Lancet 1997; 349: 1043-9
4. Merli M, Salerno F, Riggio O, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotheraphy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Hepatology 1998; 27: 40-5
5. Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patient with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996; 25: 135-44
6. Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342: 1701-7
7. Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123: 1839-47
8. Sanyal AJ, Genning C, Reddy KR, et al. The North American study for the treatment of refractory ascites. Gastroenterology 2003; 124: 634-41
9. Salerno F, Merli M, Riggio O, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004; 40: 629-35
10. Sanjal AJ, Freedman A, Shiff man ML, et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994; 20: 46-55
11. Jalan R, Elton RA, Redhead DN, et al. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the Transjugular intrahepatic portosystemic shunt for variceal haemorrhage. J Hepatol 1995; 23: 123-8
12. Somberg KA, Riegler JL, LaBerge JM, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: incidence and risk factors. Am J Gastroenterol 1995; 90: 549-55
13. Riggio O, Angeloni S, Salvatori FM, et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafl uoroethylene-covered stent graft s. Am J Gastroenterol 2008; 103: 2738-46
14. Zuckerman DA, Darcy MD, Bocchini TP, et al. Encephalopathy after transjugular intrahepatic portosystemic shunt: analysis and incidence of potential risk factors. Am J Radiol 1997; 169: 1727-31
15. Nolte W, Wiltfang J, Schindler C, et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric and electroencephalographic investigations. Hepatology 1998; 28: 1215-25
16. Riggio O, Masini A, Efrati C, et al. Pharmacological prophylaxis of hepatic encephaolpathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. J Hepatol 2005; 42: 674-9
17. Riggio O, Ridola L, Angeloni S, et al. Clinical effi cacy of transjugular intrahepatic portosystemic shunt created with covered stents with Different diameters: results of a randomized controlled trial. J Hepatol 2010; 53: 267-72
18. Bai M, Qi X, Yang Z, et al. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol 2011; 26: 943-51
19. Rossle M, Deibert P, Haag K, et al. Randomised trial of transjugular-intrahepaticportosystemicshunt versus endoscopy plus propanolol for prevention of variceal rebleeding. Lancet 1997; 349: 1043-9
20. Casado M, Bosch J, Garcia-Pagan JC, et al. Clinical events after TIPS: correlation with hemodynamic fi ndings. Gastroenterology 1998; 114: 1296-303
21. Guevara M, Baccaro ME, Rios J, et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int 2010; 30: 1137-42
22. Riggio O, Nardelli S, Pasquale C, et al. No Effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Metab Brain Dis 2015, e-pub ahead of print 20 August 2015
23. Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 2014; 60: 715-35
24. Riggio O, Amodio P, Farcomeni A, et al. A model for predicting development of overt hepatic encephalopathy in patients with cirrhosis. Clin Gastroenterol Hepatol 2015; 13: 1346-52
25. Berlioux P, Robic MA, Poirson H, et al. Pre-Transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests. Hepatology 2014; 59: 622-9
26. Sampietro G, Rossi P, Di Marco P. Use of a laryngeal mask in transjugular intrahepatic portosystemic shunt procedures. J Vasc Interv Radiol 1998; 9: 169
27. Angeloni S, Merli M, Salvatori F, et al. Polytetrafl uorethylene-covered stent-graft for TIPS procedure: 1-year patency and clinical results. Am J Gastroenterol 2004; 99: 280-5
28. Rossi P, Salvatori F, Fanelli F, et al. Polytetrafl uorethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience. Radiology 2004; 231: 820-30
29. Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573-83
30. Amodio P, Campagna F, Olianas S, et al. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantifi ed EEG study. J Hepatol 2008; 49: 346-53
31. Nicolao F, Efrati C, Masini A, et al. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. J Hepatol 2003; 38: 441-6
32. Jepsen P, Vilstrup H, Andersen PK. The clinical course of cirrhosis: the importance of multistate models and competing risks analysis. Hepatology 2015; 62: 292-302
33. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509
34. Heagerty PJ, Lumley T, Pepe MS. 2000 Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56 337-44
35. Bai M, Qi X, Yang Z, et al. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol 2011; 26: 943-51